Please login to the form below

Not currently logged in
Email:
Password:

The Directory

This page shows the latest The Directory news and features for those working in and with pharma, biotech and healthcare.

Ashfield launches ‘end-to-end’ cell and gene therapy commercialisation network

Ashfield launches ‘end-to-end’ cell and gene therapy commercialisation network

The network, called EmerGENE, combines experts from Ashfield Health, Ashfield Engage and Ashfield Advisory. ... UDG Healthcare company Ashfield has launched a new network offering an end-to-end approach for the commercialisation of cell and gene therapies

Latest news

More from news
Approximately 2 fully matching, plus 1,009 partially matching documents found.

Latest Intelligence

  • Mastering oneself Mastering oneself

    I then applied that definition to the specific context of the biomedical industry. ... Yet that is what strategists in the biomedical business are asked to do.

  • The pursuit of patient diversity in clinical trials The pursuit of patient diversity in clinical trials

    However, making the leap from good intentions to authentic achievement requires significant change. ... by expert medics – we need the broadest possible exposure to the target population.

  • Launch engagement Launch engagement

    said. “For those further behind the curve, the pandemic has accelerated their digital deployment. ... Danny Buckland is a journalist specialising in the healthcare industry. 18th May 2021.

  • Avoiding A Series of Unfortunate Events: launch lessons from lockdown Avoiding A Series of Unfortunate Events: launch lessons from lockdown

    So what are the launch lessons from lockdown? Let’s take a look. ... All these phases need proper investment, up front – and all the way through.”.

  • The new reality of building a corporate brand in pharma The new reality of building a corporate brand in pharma

    The parent companies behind the portfolios of product brands have remained in the shadows. ... Unlike other sectors, a problem with a product in the pharma sector can have a devastating effect.

More from intelligence
Approximately 0 fully matching, plus 104 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 292 partially matching documents found.

Latest from PMHub

  • Evidence-Based Adherence Strategies: behavioural medicine and the patient’s perspective. Free webinar

    We look forward to sharing these approaches in greater detail during the webinar on the 28th”. ... SoS is a UCL Business (UCLB) company. The PMLiVE website and its associated monthly print magazine Pharmaceutical Market Europe (PME) and twice-yearly

  • Disruptive change: what's the fallout?

    Welcome to the world of modern healthcare: a state of continuous disruptive change. ... This article first appeared in volumne 37 of The Directory and can be  downloaded as a pdf to read later.

  • ArgosBiotech

    As biotechnology information directory for the life sciences community, ArgosBiotech is focusing on all aspects and areas of modern biotechnology and related fields. ... ArgosBiotech.de acts as a gateway to worldwide biotech which opens up resources to

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford PharmaGenesis

Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....